Mounjaro for Weight Loss Treatment

Mounjaro, a new treatment approved by the UK’s MHRA, offers a promising option for those looking to manage their weight. It’s designed to be used with a healthy diet and exercise, helping to improve blood sugar levels and support weight management. This injectable medicine is part of a broader weight management strategy that emphasises a healthier lifestyle through dietary changes, physical activity, and behavioural adjustments.


What is Mounjaro?

Mounjaro, manufactured by Eli Lilly, is an injectable prescription medicine that alongside diet and exercise, improves blood sugar (glucose) in adults with type 2 diabetes. The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK approved Mounjaro for weight loss and weight management treatment in November 2023, making it available on prescription for both NHS and private patients.


Comprehensive Weight Management with Mounjaro

Weight loss medications like Mounjaro are typically prescribed as part of a comprehensive weight management plan. This plan includes dietary changes, increased physical activity, and behavioural modifications. Mounjaro is intended for use in conjunction with a reduced-calorie diet and increased exercise, helping individuals achieve and maintain a healthier weight.

The benefits of this multifaceted approach to weight loss go beyond aesthetics. Reducing excess weight can significantly lower the risk of health conditions such as type 2 diabetes, cardiovascular disease, and hypertension. Furthermore, it can alleviate joint pain, enhance mobility and improve overall quality of life.


How does it help with weight loss?

The active ingredient in Mounjaro, tirzepatide, works by mimicking the effects of two naturally occurring hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), by binding to their receptors.

GLP-1 plays a role in controlling blood sugar levels, which signals the brain to reduce hunger and curb cravings. Additionally, it slows stomach emptying, promoting a lasting feeling of fullness. GIP, on the other hand, manages energy balance in the brain and fat cells, amplifying GLP-1’s appetite-suppressing effect and enhancing sugar regulation. Together, they provide a comprehensive approach to weight management.


What doses are available?

Mounjaro is available in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg per 0.5 mL injection.

You’ll typically begin with a 2.5 mg dose of Mounjaro, which will go up every four weeks (or as recommended and if it works for you) until you hit your highest maintenance dose. To give your body time to adjust to the medicine and improve your chances of long-term success, our certified doctors will tailor a dosage schedule based on your requirements.


Long-term Success with Mounjaro

While medications like Mounjaro can be effective tools for weight loss, they are not magic pills. Success with Mounjaro involves regular monitoring and adjustments by healthcare professionals to ensure the treatment is safe and effective. It works best when used as part of a comprehensive weight management programme, emphasising the importance of a holistic approach to health and wellness.


How long does it take for Mounjaro to work?

Mounjaro should begin to take effect immediately, but it might take a few weeks before you notice a significant change in your blood sugar levels and how it affects your appetite and eating habits. Individual responses vary, so patience and adherence to the prescribed regimen are key.


Will I experience any side effects from using Mounjaro?

As with any medication, Mounjaro may also cause some side effects. Common side effects can include feeling sick, indigestion, constipation and diarrhoea, while less common side effects include fatigue, feeling lightheaded, flatulence, pancreatitis and gallstones.

Before starting treatment, our healthcare experts will guide you through consultation appointments and create tailored treatment plans to meet your needs and manage potential side effects effectively. For more information on our medical weight loss treatment, click here.


Who should not be taking Mounjaro?

Mounjaro is not suitable for everyone. If you or anyone in your family has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you are allergic to Mounjaro or any of its ingredients, it should not be used.

Our healthcare professionals are here to ensure your treatment journey is safe and effective, guiding you from initial consultation to ongoing support.


Start Your Mounjaro Weight Loss Journey Today

Curious about how Mounjaro can assist you on your weight loss journey? Contact Effect Doctors today to explore your weight management treatment options with one of our NMWLP-certified doctors. Whether you have questions or are ready to begin, we’re here to support you every step of the way.